Mar 8, 2018 09:01AM

Mar 6, 2018 07:32AM

Mar 6, 2018 07:30AM

Feb 23, 2018 06:20AM

Feb 13, 2018 04:15PM

Feb 8, 2018 06:23AM

Feb 8, 2018 05:56AM Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.

Feb 8, 2018 05:55AM

Jan 22, 2018 05:35AM

Jan 22, 2018 01:10AM

Jan 22, 2018 01:04AM

Jan 22, 2018 01:00AM

Nov 27, 2017 07:32AM

Nov 27, 2017 07:30AM U.S. Label Update for ALPROLIX® Adds Data Reinforcing Efficacy and Safety of Long-Term Prophylactic Treatment in Adults, Adolescents and Children with Hemophilia B

Oct 26, 2017 04:15PM

Oct 2, 2017 07:35AM

Oct 2, 2017 07:30AM

Aug 2, 2017 04:31PM

Jul 6, 2017 07:05AM

Jun 28, 2017 04:00PM

Jun 14, 2017 07:00AM Bioverativ announces FDA acceptance of Investigational New Drug Application for BIVV001, a novel, long-acting FVIII hemophilia therapeutic utilizing Amunix XTEN® half-life extension technology

Jun 12, 2017 07:04AM

Jun 12, 2017 07:00AM

May 23, 2017 07:05AM

May 23, 2017 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All